V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20030585 | 20133217 | 1.72 | null | Adjuvant (A) | 2016-12-02 | 2016-12-17 | EVEROLIMUS | 02 | N | EVEROLIMUS | 101623126 |
| 20030713 | 20133218 | 1.74 | 0 | Palliative (P) | 2017-10-23 | 2017-10-27 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101581911 |
| 20030796 | 20133219 | 1.62 | 79 | null | 2014-11-04 | 2018-03-20 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101274875 |
| 20030834 | 20133220 | 1.73 | 68.1 | Curative (C) | 2018-05-01 | 2018-05-26 | null | 02 | N | ABIRATERONE | 101351524 |
| 20030907 | 20133222 | 0 | 50 | null | 2016-12-30 | 2017-01-05 | null | 02 | null | CISPLATIN | 101198752 |
| 20030999 | 20133224 | 1.62 | 94.1 | null | 2016-08-08 | 2016-08-25 | null | null | null | OXALIPLATIN | 100846103 |
| 20031032 | 20133225 | 1.77 | 47.9 | Palliative (P) | 2020-02-18 | 2020-03-23 | null | 02 | N | SCALOP-2 TRIAL | 100832197 |
| 20031055 | 20133226 | 1.73 | null | null | null | 2018-05-10 | null | 02 | null | CETUXIMAB + ENCORAFENIB | 101625207 |
| 20031086 | 20133227 | null | 76.4 | Curative (C) | 2018-12-31 | 2018-12-31 | null | N | N | CISPLATIN + ETOPOSIDE | 100715511 |
| 20031149 | 20133229 | 1.85 | 66 | null | 2015-04-14 | 2015-04-15 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101816221 |
| 20031175 | 20133230 | 1.74 | 73.6 | null | 2017-09-25 | 2017-09-29 | null | 2 | null | LUTETIUM-177 | 101670634 |
| 20031195 | 20133231 | 0 | 77.6 | Palliative (P) | 2019-03-31 | 2019-04-29 | EVEROLIMUS | 02 | N | EVEROLIMUS | 100173461 |
| 20031197 | 20133232 | 1.8 | 74.9 | null | 2016-07-26 | 2018-08-27 | null | 02 | null | OXALIPLATIN | 101805692 |
| 20031201 | 20133233 | 1.63 | 60 | Curative (C) | null | 2020-04-13 | null | 02 | N | BEVACIZUMAB | 100863768 |
| 20031268 | 20133234 | 1.57 | 58 | Palliative (P) | 2018-09-30 | 2019-04-05 | null | 02 | N | SCALOP-2 TRIAL | 100294143 |
| 20031322 | 20133235 | 1.71 | null | Curative (C) | 2019-09-12 | 2020-02-23 | null | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100206758 |
| 20031434 | 20133236 | 1.75 | 95.3 | Palliative (P) | 2016-01-03 | 2016-01-24 | null | N | N | CARBOPLATIN + FLUOROURACIL | 100336337 |
| 20031501 | 20133237 | 1.46 | 85 | null | 2018-12-15 | 2018-12-29 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100015272 |
| 20031510 | 20133238 | 1.48 | 57.2 | null | 2018-01-05 | 2018-01-26 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 100386721 |
| 20031514 | 20133239 | 0 | null | null | null | 2015-08-13 | null | N | null | OXALIPLATIN | 101299547 |
| 20031535 | 20133240 | 1.65 | 120 | Palliative (P) | 2020-01-13 | 2020-01-23 | null | 2 | N | LENALIDOMIDE | 100735105 |
| 20031545 | 20133241 | 1.67 | 87 | null | 2017-11-08 | 2018-03-12 | null | 02 | null | LUTETIUM-177 | 100425276 |
| 20031683 | 20133242 | 1.62 | 111 | Curative (C) | 2016-08-06 | 2016-08-20 | null | null | Y | EVEROLIMUS | 101546661 |
| 20031763 | 20133244 | 1.75 | 51.9 | Palliative (P) | 2018-12-14 | 2019-01-03 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101259930 |
| 20031786 | 20133245 | null | null | null | 2021-02-07 | 2021-02-10 | EVEROLIMUS | 02 | null | EVEROLIMUS | 101590184 |
| 20031821 | 20133246 | null | 89 | Palliative (P) | 2020-01-08 | 2020-01-08 | null | N | N | TRIFLURIDINE + TIPIRACIL | 100509916 |
| 20032098 | 20133247 | 1.8 | 61.5 | Palliative (P) | 2016-04-10 | 2016-09-05 | null | 02 | N | SUNITINIB | 100651562 |
| 20032135 | 20133248 | 1.86 | 49.1 | 03 | 2019-01-28 | 2019-01-28 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 100683417 |
| 20032245 | 20133250 | 1.51 | 110 | Neo-adjuvant (N) | 2020-10-22 | 2020-10-22 | null | 02 | N | PEMBROLIZUMAB | 101459748 |
| 20032339 | 20133251 | 1.65 | 56.2 | Palliative (P) | 2019-12-29 | 2020-01-13 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100656148 |
| 20032394 | 20133252 | 1.79 | 72.2 | null | 2018-02-10 | 2018-08-01 | null | 02 | null | CISPLATIN | 100542438 |
| 20032412 | 20133253 | 1.62 | 85.8 | null | 2014-02-13 | 2016-04-17 | null | 02 | null | LUTETIUM-177 | 101447188 |
| 20032451 | 20133254 | 0 | 77.6 | null | 2020-03-09 | 2020-03-13 | null | 02 | null | NOT MATCHED | 100531827 |
| 20032500 | 20133255 | 1.73 | 84.4 | Palliative (P) | 2017-09-03 | 2018-01-01 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 101155861 |
| 20032556 | 20133256 | 1.72 | 0 | Curative (C) | 2016-01-28 | 2016-02-07 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100314680 |
| 20032585 | 20133257 | 1.56 | 0 | Palliative (P) | null | 2021-10-30 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100231228 |
| 20032626 | 20133259 | 0 | 70 | null | 2017-10-12 | 2017-12-09 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101198710 |
| 20032642 | 20133260 | 0 | 66.6 | null | 2022-01-08 | 2022-02-23 | null | 02 | null | SCALOP-2 TRIAL | 100478003 |
| 20032683 | 20133261 | 1.72 | 55.8 | Palliative (P) | 2017-09-17 | 2017-09-17 | null | 02 | N | SUNITINIB | 101127466 |
| 20032708 | 20133262 | 0 | 108.2 | 03 | 2018-08-16 | 2018-08-30 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 100053439 |
| 20032711 | 20133263 | 1.68 | 76 | Disease modification (D) | 2019-02-17 | 2020-01-31 | null | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101242406 |
| 20032721 | 20133264 | 1.73 | 74 | Curative (C) | null | 2018-11-02 | null | 02 | Y | NOT MATCHED | 101242849 |
| 20032865 | 20133265 | 1.72 | 64.4 | Curative (C) | 2019-12-01 | 2019-12-02 | null | 02 | Y | SCALOP-2 TRIAL | 100963668 |
| 20032912 | 20133267 | 1.64 | 65 | Palliative (P) | 2020-08-03 | 2020-08-05 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100455752 |
| 20032923 | 20133268 | 1.66 | 69.2 | null | 2019-04-19 | 2019-04-19 | null | N | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101446307 |
| 20032945 | 20133269 | 1.61 | 81 | Palliative (P) | 2016-03-30 | 2016-04-18 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101252481 |
| 20033069 | 20133270 | 1.74 | 62.4 | null | 2016-02-12 | 2016-02-12 | null | 02 | null | SCALOP-2 TRIAL | 100068110 |
| 20033077 | 20133271 | 1.69 | null | Palliative (P) | 2016-09-01 | 2016-09-03 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100124362 |
| 20033126 | 20133272 | 1.55 | null | Palliative (P) | 2019-12-29 | 2019-12-29 | null | 02 | Y | LENALIDOMIDE | 100325987 |
| 20033173 | 20133273 | 0 | 84.45 | Neo-adjuvant (N) | 2021-06-03 | 2021-06-24 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101424088 |